A549 cells infected with RSV Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EZH2
|
ENSG00000106462.6 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
EZH2 | hg19_v2_chr7_-_148580563_148580601 | 0.56 | 4.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_34628104 | 1.98 |
ENST00000378909.2
|
ARID3C
|
AT rich interactive domain 3C (BRIGHT-like) |
chr9_+_131902346 | 1.41 |
ENST00000432124.1
ENST00000435305.1 |
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4 |
chr11_-_44331679 | 1.01 |
ENST00000329255.3
|
ALX4
|
ALX homeobox 4 |
chr17_+_7533439 | 0.85 |
ENST00000441599.2
ENST00000380450.4 ENST00000416273.3 ENST00000575903.1 ENST00000576830.1 ENST00000571153.1 ENST00000575618.1 ENST00000576152.1 |
SHBG
|
sex hormone-binding globulin |
chr15_+_91416092 | 0.83 |
ENST00000559353.1
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
chr13_-_34250861 | 0.82 |
ENST00000445227.1
ENST00000454681.2 |
RP11-141M1.3
|
RP11-141M1.3 |
chr5_+_175298573 | 0.79 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
chr7_+_69064566 | 0.78 |
ENST00000403018.2
|
AUTS2
|
autism susceptibility candidate 2 |
chr7_-_41740181 | 0.77 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
chr2_+_121493717 | 0.77 |
ENST00000418323.1
|
GLI2
|
GLI family zinc finger 2 |
chr16_-_30997533 | 0.72 |
ENST00000602217.1
|
AC135048.1
|
Uncharacterized protein |
chr6_+_13272904 | 0.71 |
ENST00000379335.3
ENST00000379329.1 |
PHACTR1
|
phosphatase and actin regulator 1 |
chr3_+_107318157 | 0.68 |
ENST00000406780.1
|
BBX
|
bobby sox homolog (Drosophila) |
chr11_-_115158193 | 0.65 |
ENST00000543540.1
|
CADM1
|
cell adhesion molecule 1 |
chr7_-_27142290 | 0.64 |
ENST00000222718.5
|
HOXA2
|
homeobox A2 |
chr12_+_10331605 | 0.63 |
ENST00000298530.3
|
TMEM52B
|
transmembrane protein 52B |
chr16_+_29127282 | 0.60 |
ENST00000562902.1
|
RP11-426C22.5
|
RP11-426C22.5 |
chr16_-_19725899 | 0.60 |
ENST00000567367.1
|
KNOP1
|
lysine-rich nucleolar protein 1 |
chr6_-_19804877 | 0.60 |
ENST00000447250.1
|
RP4-625H18.2
|
RP4-625H18.2 |
chr19_-_36019123 | 0.59 |
ENST00000588674.1
ENST00000452271.2 ENST00000518157.1 |
SBSN
|
suprabasin |
chr2_-_219850277 | 0.58 |
ENST00000295727.1
|
FEV
|
FEV (ETS oncogene family) |
chr1_+_223354486 | 0.57 |
ENST00000446145.1
|
RP11-239E10.3
|
RP11-239E10.3 |
chr17_+_41177220 | 0.57 |
ENST00000587250.2
ENST00000544533.1 |
RND2
|
Rho family GTPase 2 |
chr7_-_75443118 | 0.57 |
ENST00000222902.2
|
CCL24
|
chemokine (C-C motif) ligand 24 |
chr18_+_70536215 | 0.56 |
ENST00000578967.1
|
RP11-676J15.1
|
RP11-676J15.1 |
chr2_+_210288760 | 0.55 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr16_+_57438679 | 0.54 |
ENST00000219244.4
|
CCL17
|
chemokine (C-C motif) ligand 17 |
chr19_-_49371711 | 0.54 |
ENST00000355496.5
ENST00000263265.6 |
PLEKHA4
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 |
chr2_+_220325441 | 0.54 |
ENST00000396688.1
|
SPEG
|
SPEG complex locus |
chr12_+_2912363 | 0.53 |
ENST00000544366.1
|
FKBP4
|
FK506 binding protein 4, 59kDa |
chr14_-_98444386 | 0.53 |
ENST00000556462.1
ENST00000556138.1 |
C14orf64
|
chromosome 14 open reading frame 64 |
chr15_+_63335899 | 0.53 |
ENST00000561266.1
|
TPM1
|
tropomyosin 1 (alpha) |
chr19_+_29493486 | 0.52 |
ENST00000589821.1
|
CTD-2081K17.2
|
CTD-2081K17.2 |
chr22_-_31688431 | 0.52 |
ENST00000402249.3
ENST00000443175.1 ENST00000215912.5 ENST00000441972.1 |
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr3_-_157824292 | 0.52 |
ENST00000483851.2
|
SHOX2
|
short stature homeobox 2 |
chr17_+_65373531 | 0.51 |
ENST00000580974.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr17_+_7387677 | 0.51 |
ENST00000322644.6
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr5_-_158526756 | 0.49 |
ENST00000313708.6
ENST00000517373.1 |
EBF1
|
early B-cell factor 1 |
chr2_-_158345341 | 0.49 |
ENST00000435117.1
|
CYTIP
|
cytohesin 1 interacting protein |
chrX_-_152989798 | 0.49 |
ENST00000441714.1
ENST00000442093.1 ENST00000429550.1 ENST00000345046.6 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr11_-_104905840 | 0.49 |
ENST00000526568.1
ENST00000393136.4 ENST00000531166.1 ENST00000534497.1 ENST00000527979.1 ENST00000446369.1 ENST00000353247.5 ENST00000528974.1 ENST00000533400.1 ENST00000525825.1 ENST00000436863.3 |
CASP1
|
caspase 1, apoptosis-related cysteine peptidase |
chr3_+_112930387 | 0.49 |
ENST00000485230.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
chr11_-_62521614 | 0.49 |
ENST00000527994.1
ENST00000394807.3 |
ZBTB3
|
zinc finger and BTB domain containing 3 |
chr1_+_209859510 | 0.48 |
ENST00000367028.2
ENST00000261465.1 |
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1 |
chr1_-_149859466 | 0.47 |
ENST00000331128.3
|
HIST2H2AB
|
histone cluster 2, H2ab |
chr7_+_129251531 | 0.47 |
ENST00000393232.1
ENST00000353868.4 ENST00000539636.1 ENST00000454688.1 ENST00000223190.4 ENST00000311967.2 |
NRF1
|
nuclear respiratory factor 1 |
chr15_-_89438742 | 0.47 |
ENST00000562281.1
ENST00000562889.1 ENST00000359595.3 |
HAPLN3
|
hyaluronan and proteoglycan link protein 3 |
chr11_+_61735266 | 0.46 |
ENST00000601917.1
|
AP003733.1
|
Uncharacterized protein; cDNA FLJ36460 fis, clone THYMU2014801 |
chr18_+_72167096 | 0.45 |
ENST00000324301.8
|
CNDP2
|
CNDP dipeptidase 2 (metallopeptidase M20 family) |
chr11_-_64764435 | 0.45 |
ENST00000534177.1
ENST00000301887.4 |
BATF2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr6_-_31550192 | 0.45 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr19_-_35981358 | 0.45 |
ENST00000484218.2
ENST00000338897.3 |
KRTDAP
|
keratinocyte differentiation-associated protein |
chr22_-_31688381 | 0.44 |
ENST00000487265.2
|
PIK3IP1
|
phosphoinositide-3-kinase interacting protein 1 |
chr15_+_90744745 | 0.44 |
ENST00000558051.1
|
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr22_+_42017987 | 0.44 |
ENST00000405506.1
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6 |
chr4_-_80994471 | 0.44 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
chr5_-_137674000 | 0.44 |
ENST00000510119.1
ENST00000513970.1 |
CDC25C
|
cell division cycle 25C |
chrX_-_100662881 | 0.43 |
ENST00000218516.3
|
GLA
|
galactosidase, alpha |
chr6_-_131277510 | 0.42 |
ENST00000525193.1
ENST00000527659.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr3_+_10312604 | 0.41 |
ENST00000426850.1
|
TATDN2
|
TatD DNase domain containing 2 |
chr1_+_152178320 | 0.41 |
ENST00000429352.1
|
RP11-107M16.2
|
RP11-107M16.2 |
chr19_+_1261106 | 0.41 |
ENST00000588411.1
|
CIRBP
|
cold inducible RNA binding protein |
chr11_-_61596753 | 0.40 |
ENST00000448607.1
ENST00000421879.1 |
FADS1
|
fatty acid desaturase 1 |
chr4_-_48082192 | 0.40 |
ENST00000507351.1
|
TXK
|
TXK tyrosine kinase |
chr11_+_57310114 | 0.40 |
ENST00000527972.1
ENST00000399154.2 |
SMTNL1
|
smoothelin-like 1 |
chr19_-_51289374 | 0.40 |
ENST00000563228.1
|
CTD-2568A17.1
|
CTD-2568A17.1 |
chr12_-_118628315 | 0.40 |
ENST00000540561.1
|
TAOK3
|
TAO kinase 3 |
chr5_+_52083730 | 0.40 |
ENST00000282588.6
ENST00000274311.2 |
ITGA1
PELO
|
integrin, alpha 1 pelota homolog (Drosophila) |
chr9_-_16870704 | 0.39 |
ENST00000380672.4
ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2
|
basonuclin 2 |
chr19_+_54412517 | 0.39 |
ENST00000391767.1
|
CACNG7
|
calcium channel, voltage-dependent, gamma subunit 7 |
chr1_+_6511651 | 0.39 |
ENST00000434576.1
|
ESPN
|
espin |
chr5_+_158527485 | 0.39 |
ENST00000517335.1
|
RP11-175K6.1
|
RP11-175K6.1 |
chr4_+_2794785 | 0.39 |
ENST00000503219.1
|
SH3BP2
|
SH3-domain binding protein 2 |
chr3_+_133292759 | 0.39 |
ENST00000431519.2
|
CDV3
|
CDV3 homolog (mouse) |
chr12_+_7167980 | 0.39 |
ENST00000360817.5
ENST00000402681.3 |
C1S
|
complement component 1, s subcomponent |
chr1_-_209824643 | 0.38 |
ENST00000391911.1
ENST00000415782.1 |
LAMB3
|
laminin, beta 3 |
chr1_+_39670360 | 0.38 |
ENST00000494012.1
|
MACF1
|
microtubule-actin crosslinking factor 1 |
chr6_+_31553978 | 0.37 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
chr7_-_139756791 | 0.37 |
ENST00000489809.1
|
PARP12
|
poly (ADP-ribose) polymerase family, member 12 |
chr14_+_23352374 | 0.37 |
ENST00000267396.4
ENST00000536884.1 |
REM2
|
RAS (RAD and GEM)-like GTP binding 2 |
chr14_-_94443105 | 0.37 |
ENST00000555019.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr10_+_1102303 | 0.37 |
ENST00000381329.1
|
WDR37
|
WD repeat domain 37 |
chr8_+_1993152 | 0.37 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
chr6_-_10413112 | 0.36 |
ENST00000465858.1
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr14_+_96829814 | 0.36 |
ENST00000555181.1
ENST00000553699.1 ENST00000554182.1 |
GSKIP
|
GSK3B interacting protein |
chr2_-_158345462 | 0.36 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
chr3_+_112929850 | 0.36 |
ENST00000464546.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
chr9_+_134103496 | 0.35 |
ENST00000498010.1
ENST00000476004.1 ENST00000528406.1 |
NUP214
|
nucleoporin 214kDa |
chr19_+_36132631 | 0.35 |
ENST00000379026.2
ENST00000379023.4 ENST00000402764.2 ENST00000479824.1 |
ETV2
|
ets variant 2 |
chr5_-_147162078 | 0.35 |
ENST00000507386.1
|
JAKMIP2
|
janus kinase and microtubule interacting protein 2 |
chr12_+_54426637 | 0.35 |
ENST00000312492.2
|
HOXC5
|
homeobox C5 |
chr2_+_169926047 | 0.35 |
ENST00000428522.1
ENST00000450153.1 ENST00000421653.1 |
DHRS9
|
dehydrogenase/reductase (SDR family) member 9 |
chr12_+_120502441 | 0.34 |
ENST00000446727.2
|
CCDC64
|
coiled-coil domain containing 64 |
chr10_+_91152303 | 0.34 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr6_-_51952418 | 0.34 |
ENST00000371117.3
|
PKHD1
|
polycystic kidney and hepatic disease 1 (autosomal recessive) |
chr16_-_89785777 | 0.34 |
ENST00000561976.1
|
VPS9D1
|
VPS9 domain containing 1 |
chr16_+_30075783 | 0.34 |
ENST00000412304.2
|
ALDOA
|
aldolase A, fructose-bisphosphate |
chr1_+_66796401 | 0.34 |
ENST00000528771.1
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr2_+_105858200 | 0.34 |
ENST00000258456.1
|
GPR45
|
G protein-coupled receptor 45 |
chr1_-_201342364 | 0.34 |
ENST00000236918.7
ENST00000367317.4 ENST00000367315.2 ENST00000360372.4 |
TNNT2
|
troponin T type 2 (cardiac) |
chr16_+_80574854 | 0.33 |
ENST00000305904.6
ENST00000568035.1 |
DYNLRB2
|
dynein, light chain, roadblock-type 2 |
chr11_-_71751715 | 0.33 |
ENST00000535947.1
|
NUMA1
|
nuclear mitotic apparatus protein 1 |
chr5_-_141257954 | 0.33 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
chr6_+_123100620 | 0.33 |
ENST00000368444.3
|
FABP7
|
fatty acid binding protein 7, brain |
chr3_-_71179988 | 0.33 |
ENST00000491238.1
|
FOXP1
|
forkhead box P1 |
chr12_-_116714564 | 0.32 |
ENST00000548743.1
|
MED13L
|
mediator complex subunit 13-like |
chr12_-_49730970 | 0.32 |
ENST00000334221.3
|
C1QL4
|
complement component 1, q subcomponent-like 4 |
chrX_+_48542168 | 0.32 |
ENST00000376701.4
|
WAS
|
Wiskott-Aldrich syndrome |
chr11_-_123065989 | 0.32 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
chrX_-_100129320 | 0.32 |
ENST00000372966.3
|
NOX1
|
NADPH oxidase 1 |
chr5_+_175298674 | 0.32 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
chr3_-_124839648 | 0.32 |
ENST00000430155.2
|
SLC12A8
|
solute carrier family 12, member 8 |
chr13_-_45048386 | 0.31 |
ENST00000472477.1
|
TSC22D1
|
TSC22 domain family, member 1 |
chr2_-_198540751 | 0.31 |
ENST00000429081.1
|
RFTN2
|
raftlin family member 2 |
chr1_-_101360205 | 0.31 |
ENST00000450240.1
|
EXTL2
|
exostosin-like glycosyltransferase 2 |
chr8_+_1993173 | 0.31 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
chr11_+_114168773 | 0.31 |
ENST00000542647.1
ENST00000545255.1 |
NNMT
|
nicotinamide N-methyltransferase |
chr22_-_36236265 | 0.31 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr3_+_197464046 | 0.31 |
ENST00000428738.1
|
FYTTD1
|
forty-two-three domain containing 1 |
chr10_+_3146868 | 0.30 |
ENST00000415005.1
ENST00000468050.1 |
PFKP
|
phosphofructokinase, platelet |
chr12_+_6881678 | 0.30 |
ENST00000441671.2
ENST00000203629.2 |
LAG3
|
lymphocyte-activation gene 3 |
chr1_+_36621529 | 0.30 |
ENST00000316156.4
|
MAP7D1
|
MAP7 domain containing 1 |
chr6_+_123100853 | 0.30 |
ENST00000356535.4
|
FABP7
|
fatty acid binding protein 7, brain |
chrX_-_129299847 | 0.30 |
ENST00000319908.3
ENST00000287295.3 |
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1 |
chr1_-_151804314 | 0.30 |
ENST00000318247.6
|
RORC
|
RAR-related orphan receptor C |
chr12_-_49582978 | 0.30 |
ENST00000301071.7
|
TUBA1A
|
tubulin, alpha 1a |
chr1_+_161195781 | 0.30 |
ENST00000367988.3
|
TOMM40L
|
translocase of outer mitochondrial membrane 40 homolog (yeast)-like |
chr8_-_21646311 | 0.30 |
ENST00000524240.1
ENST00000400782.4 |
GFRA2
|
GDNF family receptor alpha 2 |
chr6_+_31543334 | 0.30 |
ENST00000449264.2
|
TNF
|
tumor necrosis factor |
chr4_-_37687991 | 0.29 |
ENST00000314117.4
ENST00000454158.2 |
RELL1
|
RELT-like 1 |
chr11_-_104972158 | 0.29 |
ENST00000598974.1
ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1
CARD16
CARD17
|
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr17_+_18218587 | 0.29 |
ENST00000406438.3
|
SMCR8
|
Smith-Magenis syndrome chromosome region, candidate 8 |
chr10_-_13570533 | 0.29 |
ENST00000396900.2
ENST00000396898.2 |
BEND7
|
BEN domain containing 7 |
chr12_-_118628350 | 0.29 |
ENST00000537952.1
ENST00000537822.1 |
TAOK3
|
TAO kinase 3 |
chr2_+_220462560 | 0.29 |
ENST00000456909.1
ENST00000295641.10 |
STK11IP
|
serine/threonine kinase 11 interacting protein |
chr1_+_175036966 | 0.29 |
ENST00000239462.4
|
TNN
|
tenascin N |
chr11_+_35222629 | 0.29 |
ENST00000526553.1
|
CD44
|
CD44 molecule (Indian blood group) |
chr1_-_190446759 | 0.29 |
ENST00000367462.3
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3 |
chr20_-_35580240 | 0.29 |
ENST00000262878.4
|
SAMHD1
|
SAM domain and HD domain 1 |
chr14_+_93118813 | 0.29 |
ENST00000556418.1
|
RIN3
|
Ras and Rab interactor 3 |
chr17_+_71161140 | 0.29 |
ENST00000357585.2
|
SSTR2
|
somatostatin receptor 2 |
chr2_+_217363559 | 0.29 |
ENST00000600880.1
ENST00000446558.1 |
RPL37A
|
ribosomal protein L37a |
chr2_+_201994042 | 0.29 |
ENST00000417748.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr6_+_31895480 | 0.29 |
ENST00000418949.2
ENST00000383177.3 ENST00000477310.1 |
C2
CFB
|
complement component 2 Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr16_+_30075595 | 0.29 |
ENST00000563060.2
|
ALDOA
|
aldolase A, fructose-bisphosphate |
chr14_+_23305760 | 0.28 |
ENST00000311852.6
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted) |
chr5_+_121647877 | 0.28 |
ENST00000514497.2
ENST00000261367.7 |
SNCAIP
|
synuclein, alpha interacting protein |
chr6_+_31895467 | 0.28 |
ENST00000556679.1
ENST00000456570.1 |
CFB
CFB
|
complement factor B Complement factor B; Uncharacterized protein; cDNA FLJ55673, highly similar to Complement factor B |
chr5_-_141249154 | 0.28 |
ENST00000357517.5
ENST00000536585.1 |
PCDH1
|
protocadherin 1 |
chr9_-_107690420 | 0.28 |
ENST00000423487.2
ENST00000374733.1 ENST00000374736.3 |
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1 |
chr7_+_138818490 | 0.28 |
ENST00000430935.1
ENST00000495038.1 ENST00000474035.2 ENST00000478836.2 ENST00000464848.1 ENST00000343187.4 |
TTC26
|
tetratricopeptide repeat domain 26 |
chr11_-_17410869 | 0.28 |
ENST00000528731.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
chr12_+_113376249 | 0.28 |
ENST00000551007.1
ENST00000548514.1 |
OAS3
|
2'-5'-oligoadenylate synthetase 3, 100kDa |
chrX_-_153141302 | 0.28 |
ENST00000361699.4
ENST00000543994.1 ENST00000370057.3 ENST00000538883.1 ENST00000361981.3 |
L1CAM
|
L1 cell adhesion molecule |
chr11_+_47608198 | 0.28 |
ENST00000356737.2
ENST00000538490.1 |
FAM180B
|
family with sequence similarity 180, member B |
chr1_-_153521714 | 0.28 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr16_-_67281413 | 0.27 |
ENST00000258201.4
|
FHOD1
|
formin homology 2 domain containing 1 |
chr4_-_80994210 | 0.27 |
ENST00000403729.2
|
ANTXR2
|
anthrax toxin receptor 2 |
chr9_+_34653861 | 0.27 |
ENST00000556792.1
ENST00000318041.9 ENST00000378817.4 |
IL11RA
|
interleukin 11 receptor, alpha |
chr19_-_39881669 | 0.27 |
ENST00000221266.7
|
PAF1
|
Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae) |
chrX_-_152989531 | 0.27 |
ENST00000458587.2
ENST00000416815.1 |
BCAP31
|
B-cell receptor-associated protein 31 |
chr19_-_51504852 | 0.27 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
chr2_+_217363826 | 0.27 |
ENST00000441179.2
|
RPL37A
|
ribosomal protein L37a |
chr22_+_24990746 | 0.27 |
ENST00000456869.1
ENST00000411974.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chr6_-_18264406 | 0.27 |
ENST00000515742.1
|
DEK
|
DEK oncogene |
chr1_+_225600404 | 0.27 |
ENST00000366845.2
|
AC092811.1
|
AC092811.1 |
chr3_+_29322437 | 0.26 |
ENST00000434693.2
|
RBMS3
|
RNA binding motif, single stranded interacting protein 3 |
chr17_-_36904437 | 0.26 |
ENST00000585100.1
ENST00000360797.2 ENST00000578109.1 ENST00000579882.1 |
PCGF2
|
polycomb group ring finger 2 |
chr4_-_80994619 | 0.26 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
chr17_+_48133459 | 0.26 |
ENST00000320031.8
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
chr1_-_198906528 | 0.26 |
ENST00000432296.1
|
MIR181A1HG
|
MIR181A1 host gene (non-protein coding) |
chr1_-_205180664 | 0.26 |
ENST00000367161.3
ENST00000367162.3 ENST00000367160.4 |
DSTYK
|
dual serine/threonine and tyrosine protein kinase |
chr11_+_57105991 | 0.26 |
ENST00000263314.2
|
P2RX3
|
purinergic receptor P2X, ligand-gated ion channel, 3 |
chr1_-_155112883 | 0.26 |
ENST00000368399.1
ENST00000368400.4 ENST00000341298.3 |
DPM3
|
dolichyl-phosphate mannosyltransferase polypeptide 3 |
chr16_+_58033450 | 0.26 |
ENST00000561743.1
|
USB1
|
U6 snRNA biogenesis 1 |
chr7_+_140396756 | 0.26 |
ENST00000460088.1
ENST00000472695.1 |
NDUFB2
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa |
chr19_+_39138320 | 0.26 |
ENST00000424234.2
ENST00000390009.3 ENST00000589528.1 |
ACTN4
|
actinin, alpha 4 |
chr4_+_113568207 | 0.26 |
ENST00000511529.1
|
LARP7
|
La ribonucleoprotein domain family, member 7 |
chr1_+_179851893 | 0.25 |
ENST00000531630.2
|
TOR1AIP1
|
torsin A interacting protein 1 |
chr8_-_42065075 | 0.25 |
ENST00000429089.2
ENST00000519510.1 ENST00000429710.2 ENST00000524009.1 |
PLAT
|
plasminogen activator, tissue |
chr12_+_58087901 | 0.25 |
ENST00000315970.7
ENST00000547079.1 ENST00000439210.2 ENST00000389146.6 ENST00000413095.2 ENST00000551035.1 ENST00000257966.8 ENST00000435406.2 ENST00000550372.1 ENST00000389142.5 |
OS9
|
osteosarcoma amplified 9, endoplasmic reticulum lectin |
chr1_+_9242221 | 0.25 |
ENST00000412639.2
|
RP3-510D11.2
|
RP3-510D11.2 |
chr16_+_30773636 | 0.25 |
ENST00000402121.3
ENST00000565995.1 ENST00000563683.1 ENST00000357890.5 ENST00000565931.1 |
RNF40
|
ring finger protein 40, E3 ubiquitin protein ligase |
chr18_-_53735601 | 0.25 |
ENST00000589754.1
|
CTD-2008L17.2
|
CTD-2008L17.2 |
chr10_+_96698406 | 0.25 |
ENST00000260682.6
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
chr1_+_214161272 | 0.25 |
ENST00000498508.2
ENST00000366958.4 |
PROX1
|
prospero homeobox 1 |
chr5_-_20575959 | 0.24 |
ENST00000507958.1
|
CDH18
|
cadherin 18, type 2 |
chr17_-_79980734 | 0.24 |
ENST00000584600.1
ENST00000584347.1 ENST00000580435.1 ENST00000306704.6 ENST00000392359.3 |
STRA13
|
stimulated by retinoic acid 13 |
chr17_+_65374075 | 0.24 |
ENST00000581322.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr9_+_133971909 | 0.24 |
ENST00000247291.3
ENST00000372302.1 ENST00000372300.1 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1-like |
chr17_-_73781567 | 0.24 |
ENST00000586607.1
|
H3F3B
|
H3 histone, family 3B (H3.3B) |
chr11_-_66112555 | 0.24 |
ENST00000425825.2
ENST00000359957.3 |
BRMS1
|
breast cancer metastasis suppressor 1 |
chr12_-_56652111 | 0.24 |
ENST00000267116.7
|
ANKRD52
|
ankyrin repeat domain 52 |
chrX_+_16964794 | 0.24 |
ENST00000357277.3
|
REPS2
|
RALBP1 associated Eps domain containing 2 |
chr10_+_98741041 | 0.24 |
ENST00000286067.2
|
C10orf12
|
chromosome 10 open reading frame 12 |
chr14_-_23284703 | 0.24 |
ENST00000555911.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
chr1_-_153581798 | 0.24 |
ENST00000368704.1
ENST00000368705.2 |
S100A16
|
S100 calcium binding protein A16 |
chr15_+_81293254 | 0.24 |
ENST00000267984.2
|
MESDC1
|
mesoderm development candidate 1 |
chr10_-_46089939 | 0.24 |
ENST00000453980.3
|
MARCH8
|
membrane-associated ring finger (C3HC4) 8, E3 ubiquitin protein ligase |
chr1_-_151804222 | 0.24 |
ENST00000392697.3
|
RORC
|
RAR-related orphan receptor C |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.8 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.3 | 0.8 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.3 | 0.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.7 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.2 | 0.6 | GO:0021569 | rhombomere 3 development(GO:0021569) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 1.0 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 0.8 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.2 | 0.3 | GO:0048565 | digestive tract development(GO:0048565) |
0.1 | 0.4 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 0.4 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
0.1 | 0.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.9 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.4 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.1 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.1 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 0.6 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 0.5 | GO:0021623 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
0.1 | 0.3 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.1 | 0.2 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.1 | 0.3 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.1 | 0.2 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.1 | 0.3 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.5 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.1 | 0.8 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.5 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.3 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.2 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 0.3 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 0.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.1 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.5 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.1 | 0.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.1 | 0.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.1 | 0.3 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.2 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.3 | GO:0032489 | aminophospholipid transport(GO:0015917) regulation of Cdc42 protein signal transduction(GO:0032489) regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.1 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.4 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.1 | 0.2 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.4 | GO:0001705 | ectoderm formation(GO:0001705) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.2 | GO:1904204 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
0.1 | 0.2 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.2 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.1 | GO:0051495 | positive regulation of cytoskeleton organization(GO:0051495) |
0.0 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.3 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 0.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.6 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.0 | 0.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.0 | 0.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.0 | 0.2 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
0.0 | 0.2 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.0 | 0.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.7 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 1.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.2 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.3 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.0 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
0.0 | 0.1 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.0 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 | 0.2 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.0 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) glycosylceramide catabolic process(GO:0046477) |
0.0 | 0.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.0 | 0.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.2 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.3 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.0 | 0.1 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.4 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.0 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.7 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.0 | 0.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.0 | GO:1904640 | response to methionine(GO:1904640) |
0.0 | 0.0 | GO:0003335 | corneocyte development(GO:0003335) |
0.0 | 0.3 | GO:1902846 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
0.0 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.0 | 0.1 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.0 | 0.1 | GO:0036343 | psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
0.0 | 0.3 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
0.0 | 0.1 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.0 | 0.1 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.4 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.4 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.0 | 0.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.0 | 0.3 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.0 | 0.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.0 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.0 | 0.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.2 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.6 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.0 | 0.6 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.1 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.0 | 0.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.0 | 0.4 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.0 | 0.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.1 | GO:0006696 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.0 | 0.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.3 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.0 | 0.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.2 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.0 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.0 | 0.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.4 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.2 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.0 | 0.2 | GO:1902527 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.2 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.1 | GO:0015878 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.0 | 0.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.0 | 0.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.1 | GO:1990834 | response to odorant(GO:1990834) |
0.0 | 0.2 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.1 | GO:0010737 | protein kinase A signaling(GO:0010737) regulation of protein kinase A signaling(GO:0010738) |
0.0 | 0.1 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.0 | 0.5 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.2 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.0 | 0.1 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.0 | 0.1 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.0 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.1 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.0 | 0.5 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.0 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.0 | 0.0 | GO:0044362 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 0.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.4 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.0 | 0.2 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.7 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.0 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.0 | 0.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.7 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0070543 | response to linoleic acid(GO:0070543) |
0.0 | 0.0 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) positive regulation of endodeoxyribonuclease activity(GO:0032079) regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 0.0 | GO:1903566 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 1.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.0 | 0.1 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.0 | 0.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.0 | 0.0 | GO:0061055 | myotome development(GO:0061055) |
0.0 | 0.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 0.5 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 1.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.8 | GO:0097169 | NLRP1 inflammasome complex(GO:0072558) AIM2 inflammasome complex(GO:0097169) protease inhibitor complex(GO:0097179) |
0.1 | 0.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 0.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.1 | 0.9 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
0.1 | 0.4 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.1 | 0.4 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 0.2 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.1 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.1 | 0.2 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 0.2 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 0.2 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.2 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.9 | GO:0032059 | bleb(GO:0032059) |
0.0 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.3 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 0.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 1.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0031905 | early endosome lumen(GO:0031905) |
0.0 | 0.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.3 | GO:0055028 | cortical microtubule(GO:0055028) |
0.0 | 0.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.6 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.3 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.1 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.0 | 0.6 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.0 | 0.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.1 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.0 | 0.3 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.4 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.5 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.2 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 1.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.6 | GO:0031430 | M band(GO:0031430) |
0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 1.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.1 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.0 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.0 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 0.7 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 0.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.5 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.6 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.7 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.1 | 0.4 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.1 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.4 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 0.3 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 1.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.8 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 0.3 | GO:0030172 | troponin C binding(GO:0030172) |
0.1 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.2 | GO:0033677 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.3 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.1 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.1 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.2 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.1 | 0.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.0 | 0.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.2 | GO:0035651 | AP-1 adaptor complex binding(GO:0035650) AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.2 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.0 | 1.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.0 | 0.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.0 | 0.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 1.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.0 | 0.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.0 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.0 | 0.4 | GO:0038064 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
0.0 | 0.2 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 1.0 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.0 | 0.1 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.4 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.0 | 0.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.0 | 0.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.0 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.3 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.0 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 0.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 0.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.0 | 0.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.0 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.0 | 0.9 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.0 | 0.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.4 | GO:0038191 | neuropilin binding(GO:0038191) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.5 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.0 | 0.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 1.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 1.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |